Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Strategies on Reducing Morbidity and Mortality from Invasive Aspergillosis and Other Serious Fungal Infections
Boston, Massachusetts / September 12-15, 2010
Boston - Several strategies to reduce the rates of morbidity and mortality generated by invasive fungal infections over those currently achieved on guideline-directed care are being pursued simultaneously. Although targeted antifungal...
PRIORITY PRESS - 17th International Pathogenic Neisseria Conference
Meningococcal Disease: Quadrivalent Vaccine Efficacy and Emerging Vaccine Against Serogroup B Disease
Banff, Alberta / September 11-16, 2010
Invasive meningococcal disease is rare but potentially fatal and is often associated with significant clinical sequelae. Distribution of the five major serogroups which cause invasive meningococcal disease—A, B, C, W-135 and...
MEDICAL OPTIONS - Gastroenterology
Mucosal Healing and Treatment Paradigms in Inflammatory Bowel Disease
THE IMPORTANCE OF MUCOSAL HEALING IN CROHN’S DISEASE Editorial review: Subrata Ghosh, MD, FRCPC, FRCP(E) Head, Division of Gastroenterology, Teaching Research Wellness Building, Professor of Medicine, University of Calgary,...
PRIORITY PRESS - 13th World Congress on Pain
Addressing Chronic Pain and Mood States
Montreal, Quebec / August 29-September 3, 2010
Montreal - Chronic pain is increasingly regarded as a disease entity in its own right which has implications for both assessment and management. In chronic pain states such as diabetic peripheral neuropathy and fibromyalgia, evaluation of...
MEDICAL FRONTIERS - European Society of Cardiology (ESC) 2010 Congress
New Focus on Predictability of Antiplatelet Response Generated by P2Y12 Inhibition Trials
Stockholm, Sweden / August 28-September 1, 2010
Stockholm - Individual variability of response to ASA and clopidogrel has shifted attention from the potency of antiplatelet agents to their predictability. Several large clinical trials have demonstrated that newer antiplatelet agents...
MEDICAL FRONTIERS - European Society of Cardiology (ESC) 2010 Congress
Reversible Antiplatelet Agents: Increased Versatility in the Management of Acute Coronary Syndromes
Stockholm, Sweden / August 28-September 1, 2010
Stockholm - In an effort to further reduce the risk of second thrombotic events during and after a myocardial infarction (MI) or other acute coronary syndrome (ACS) events, newer antiplatelet agents are not just being designed to produce a...
PRIORITY PRESS - 23rd Congress of the European College of Neuropsychopharmacology
Management of Major Depressive Disorder: The Role of Atypical Antipsychotics
Amsterdam, The Netherlands / August 28-September 1, 2010
“Severe depression is the most important dimension of a complex and heterogeneous condition that includes anxiety, suicidality and multiple medical comorbidities that are urgent to treat,” according to Dr. Michael E. Thase, Director, Mood...
PRIORITY PRESS - European Society of Cardiology (ESC) 2010 Congress
Treating Patients at Intermediate Cardiovascular Risk
Stockholm, Sweden / August 28-September 1, 2010
Stockholm - Many patients who can reduce their risk of cardiovascular (CV) events by lipid lowering are being missed entirely by treatment based on LDL-C as an isolated risk factor. In traditional high-risk patients, such as those with a...
RESOURCE LINE
VACCINE
July-September 2010
Quadrivalent HPV vaccine: strong, sustained protection against low-grade lesions Dillner J and the FUTURE I/II Study Group. Four-year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low-grade cervical, vulvar, and...